The Potential of Drug Delivery Nanosystems for Sepsis Treatment

References

• GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789–1858. doi:10.1016/S0140-6736(18)32279-7
   PubMed Web of Science ®Google Scholar
• Prescott HC, Angus DC. Enhancing recovery from sepsis: a review. JAMA. 2018;319(1):62–75. doi:10.1001/jama.2017.17687
   PubMed Web of Science ®Google Scholar
• Gauer R, Forbes D, Boyer N. Sepsis: diagnosis and management. Am Fam Physician. 2020;101(7):409–418.
   PubMed Web of Science ®Google Scholar
• Evans T. Diagnosis and management of sepsis. Clin Med. 2018;18(2):146–149. doi:10.7861/clinmedicine.18-2-146
   PubMed Web of Science ®Google Scholar
• Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200–211. doi:10.1016/S0140-6736(19)32989-7
   PubMed Web of Science ®Google Scholar
• Thompson K, Venkatesh B, Finfer S. Sepsis and septic shock: current approaches to management. Intern Med J. 2019;49(2):160–170. doi:10.1111/imj.14199
   PubMed Web of Science ®Google Scholar
• Hunt A. Sepsis: an overview of the signs, symptoms, diagnosis, treatment and pathophysiology. Emerg Nurse. 2019;27:32–41. doi:10.7748/en.2019.e1926
   PubMedGoogle Scholar
• Pant A, Mackraj I, Govender T. Advances in sepsis diagnosis and management: a paradigm shift towards nanotechnology. J Biomed Sci. 2021;28(1):6. doi:10.1186/s12929-020-00702-6
   PubMed Web of Science ®Google Scholar
• Schrag SJ, Farley MM, Petit S, et al. Epidemiology of invasive early-onset neonatal sepsis, 2005 to 2014. Pediatrics. 2016;138(6):e20162013. doi:10.1542/peds.2016-2013
   PubMed Web of Science ®Google Scholar
• Popescu CR, Cavanagh MMM, Tembo B, et al. Neonatal sepsis in low-income countries: epidemiology, diagnosis and prevention. Expert Rev Anti Infect Ther. 2020;18(5):443–452. doi:10.1080/14787210.2020.1732818
   PubMed Web of Science ®Google Scholar
• Chauhan N, Tiwari S, Jain U. Potential biomarkers for effective screening of neonatal sepsis infections: an overview. Microb Pathog. 2017;107:234–242. doi:10.1016/j.micpath.2017.03.042
   PubMed Web of Science ®Google Scholar
• Balayan S, Chauhan N, Chandra R, Kuchhal NK, Jain U. Recent advances in developing biosensing based platforms for neonatal sepsis. Biosens Bioelectron. 2020;169:112552. doi:10.1016/j.bios.2020.112552
   PubMed Web of Science ®Google Scholar
• Zahednezhad F, Saadat M, Valizadeh H, Zakeri-Milani P, Baradaran B. Liposome and immune system interplay: challenges and potentials. J Control Release. 2019;305:194–209. doi:10.1016/j.jconrel.2019.05.030
   PubMed Web of Science ®Google Scholar
• Patil YP, Jadhav S. Novel methods for liposome preparation. Chem Phys Lipids. 2014;177:8–18. doi:10.1016/j.chemphyslip.2013.10.011
   PubMed Web of Science ®Google Scholar
• De Jong WH, Borm PJ. Drug delivery and nanoparticles: applicationsand hazards. Int J Nanomedicine. 2008;3(2):133–149. doi:10.2147/IJN.S596
   PubMed Web of Science ®Google Scholar
• Rajpoot K. Solid lipid nanoparticles: a promising nanomaterial in drug delivery. Curr Pharm Des. 2019;25(37):3943–3959. doi:10.2174/1381612825666190903155321
   PubMed Web of Science ®Google Scholar
• Lin M, Dai Y, Xia F, Zhang X. Advances in non-covalent crosslinked polymer micelles for biomedical applications. Mater Sci Eng C Mater Biol Appl. 2021;119:111626. doi:10.1016/j.msec.2020.111626
   PubMed Web of Science ®Google Scholar
• Jin X, Sun P, Tong G, Zhu X. Star polymer-based unimolecular micelles and their application in bio-imaging and diagnosis. Biomaterials. 2018;178:738–750. doi:10.1016/j.biomaterials.2018.01.051
   PubMed Web of Science ®Google Scholar
• Vader P, Mol EA, Pasterkamp G, Schiffelers RM. Extracellular vesicles for drug delivery. Adv Drug Deliv Rev. 2016;106(Pt A):148–156. doi:10.1016/j.addr.2016.02.006
   PubMed Web of Science ®Google Scholar
• Wang S, Gao J, Wang Z. Outer membrane vesicles for vaccination and targeted drug delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019;11(2):e1523. doi:10.1002/wnan.1523
   PubMed Web of Science ®Google Scholar
• Surman M, Drożdż A, Stępień E, Przybyło M. Extracellular vesicles as drug delivery systems - methods of production and potential therapeutic applications. Curr Pharm Des. 2019;25(2):132–154. doi:10.2174/1381612825666190306153318
   PubMed Web of Science ®Google Scholar
• Jin F, Liu D, Yu H, et al. Sialic acid-functionalized PEG-PLGA microspheres loading mitochondrial-targeting-modified curcumin for acute lung injury therapy. Mol Pharm. 2019;16(1):71–85. doi:10.1021/acs.molpharmaceut.8b00861
   PubMedGoogle Scholar
• Dolman ME, Harmsen S, Storm G, Hennink WE, Kok RJ. Drug targeting to the kidney: advances in the active targeting of therapeutics to proximal tubular cells. Adv Drug Deliv Rev. 2010;62(14):1344–1357. doi:10.1016/j.addr.2010.07.011
   PubMed Web of Science ®Google Scholar
• Liu D, Shu G, Jin F, et al. ROS-responsive chitosan-SS31 prodrug for AKI therapy via rapid distribution in the kidney and long-term retention in the renal tubule. Sci Adv. 2020;6(41):eabb7422. doi:10.1126/sciadv.abb7422
   PubMed Web of Science ®Google Scholar
• Fan X, Fan J, Wang X, Wu P, Wu G. S-thanatin functionalized liposome potentially targeting on Klebsiella pneumoniae and its application in sepsis mouse model. Front Pharmacol. 2015;6:249. doi:10.3389/fphar.2015.00249
   PubMed Web of Science ®Google Scholar
• Jiang S, Li S, Hu J, et al. Combined delivery of angiopoietin-1 gene and simvastatin mediated by anti-intercellular adhesion molecule-1 antibody-conjugated ternary nanoparticles for acute lung injury therapy. Nanomedicine. 2019;15(1):25–36. doi:10.1016/j.nano.2018.08.009
   PubMed Web of Science ®Google Scholar
• Qi J, Li W, Xu X, et al. Cyto-friendly polymerization at cell surfaces modulates cell fate by clustering cell-surface receptors. Chem Sci. 2020;11(16):4221–4225. doi:10.1039/C9SC06385D
   PubMed Web of Science ®Google Scholar
• Sadikot RT. The potential role of nano- and micro-technology in the management of critical illnesses. Adv Drug Deliv Rev. 2014;77:27–31. doi:10.1016/j.addr.2014.07.004
   PubMed Web of Science ®Google Scholar
• Kumar S, Tripathy S, Jyoti A, Singh SG. Recent advances in biosensors for diagnosis and detection of sepsis: a comprehensive review. Biosens Bioelectron. 2019;124–125:205–215. doi:10.1016/j.bios.2018.10.034
   PubMed Web of Science ®Google Scholar
• Buxton DB. Nanomedicine for the management of lung and blood diseases. Nanomedicine. 2009;4(3):331–339. doi:10.2217/nnm.09.8
   PubMed Web of Science ®Google Scholar
• Zhang CY, Gao J, Wang Z. Bioresponsive nanoparticles targeted to infectious microenvironments for sepsis management. Adv Mater. 2018;30:e1803618. doi:10.1002/adma.201803618
   PubMed Web of Science ®Google Scholar
• Hou X, Zhang X, Zhao W, et al. Vitamin lipid nanoparticles enable adoptive macrophage transfer for the treatment of multidrug-resistant bacterial sepsis. Nat Nanotechnol. 2020;15(1):41–46. doi:10.1038/s41565-019-0600-1
   PubMed Web of Science ®Google Scholar
• Ben-Akiva E, Meyer RA, Yu H, et al. Biomimetic anisotropic polymeric nanoparticles coated with red blood cell membranes for enhanced circulation and toxin removal. Sci Adv. 2020;6(16):eaay9035. doi:10.1126/sciadv.aay9035
   PubMed Web of Science ®Google Scholar
• Zheng H, Ma R, Gao M, et al. Antibacterial applications of graphene oxides: structure-activity relationships, molecular initiating events and biosafety. Sci Bull. 2018;63(2):133–142. doi:10.1016/j.scib.2017.12.012
   PubMed Web of Science ®Google Scholar
• Yim D, Lee DE, So Y, et al. Sustainable nanosheet antioxidants for sepsis therapy via scavenging intracellular reactive oxygen and nitrogen species. ACS Nano. 2020;14(8):10324–10336. doi:10.1021/acsnano.0c03807
   PubMed Web of Science ®Google Scholar
• Weng Q, Sun H, Fang C, et al. Catalytic activity tunable ceria nanoparticles prevent chemotherapy-induced acute kidney injury without interference with chemotherapeutics. Nat Commun. 2021;12(1):1436. doi:10.1038/s41467-021-21714-2
   PubMed Web of Science ®Google Scholar
• Kwon HJ, Cha MY, Kim D, et al. Mitochondria-targeting ceria nanoparticles as antioxidants for Alzheimer’s disease. ACS Nano. 2016;10(2):2860–2870. doi:10.1021/acsnano.5b08045
   PubMed Web of Science ®Google Scholar
• Ni D, Wei H, Chen W, et al. Ceria nanoparticles meet hepatic ischemia-reperfusion injury: the perfect imperfection. Adv Mater. 2019;31(40):e1902956. doi:10.1002/adma.201902956
   PubMed Web of Science ®Google Scholar
• Kim J, Kim HY, Song SY, et al. Synergistic oxygen generation and reactive oxygen species scavenging by manganese ferrite/ceria co-decorated nanoparticles for rheumatoid arthritis treatment. ACS Nano. 2019;13(3):3206–3217. doi:10.1021/acsnano.8b08785
   PubMed Web of Science ®Google Scholar
• Chen G, Xu Y. Biosynthesis of cerium oxide nanoparticles and their effect on lipopolysaccharide (LPS) induced sepsis mortality and associated hepatic dysfunction in male Sprague Dawley rats. Mater Sci Eng C Mater Biol Appl. 2018;83:148–153. doi:10.1016/j.msec.2017.11.014
   PubMed Web of Science ®Google Scholar
• Yu H, Jin F, Liu D, et al. ROS-responsive nano-drug delivery system combining mitochondria-targeting ceria nanoparticles with atorvastatin for acute kidney injury. Theranostics. 2020;10(5):2342–2357. doi:10.7150/thno.40395
   PubMed Web of Science ®Google Scholar
• Zhang CY, Dong X, Gao J, Lin W, Liu Z, Wang Z. Nanoparticle-induced neutrophil apoptosis increases survival in sepsis and alleviates neurological damage in stroke. Sci Adv. 2019;5(11):eaax7964. doi:10.1126/sciadv.aax7964
   PubMed Web of Science ®Google Scholar
• Wang Z, Li J, Cho J, Malik AB. Prevention of vascular inflammation by nanoparticle targeting of adherent neutrophils. Nat Nanotechnol. 2014;9(3):204–210. doi:10.1038/nnano.2014.17
   PubMed Web of Science ®Google Scholar
• Wang J, Wang H, Zhu R, Liu Q, Fei J, Wang S. Anti-inflammatory activity of curcumin-loaded solid lipid nanoparticles in IL-1β transgenic mice subjected to the lipopolysaccharide-induced sepsis. Biomaterials. 2015;53:475–483. doi:10.1016/j.biomaterials.2015.02.116
   PubMed Web of Science ®Google Scholar
• Dawulieti J, Sun M, Zhao Y, et al. Treatment of severe sepsis with nanoparticulate cell-free DNA scavengers. Sci Adv. 2020;6(22):eaay7148. doi:10.1126/sciadv.aay7148
   PubMed Web of Science ®Google Scholar
• Mohr AM, Mott JL. Overview of microRNA biology. Semin Liver Dis. 2015;35(1):3–11. doi:10.1055/s-0034-1397344
   PubMed Web of Science ®Google Scholar
• Kemp JA, Kwon YJ. Cancer nanotechnology: current status and perspectives. Nano Converg. 2021;8(1):34. doi:10.1186/s40580-021-00282-7
   PubMed Web of Science ®Google Scholar
• Revia RA, Stephen ZR, Zhang M. Theranostic nanoparticles for RNA-based cancer treatment. Acc Chem Res. 2019;52(6):1496–1506. doi:10.1021/acs.accounts.9b00101
   PubMed Web of Science ®Google Scholar
• Jones Buie JN, Zhou Y, Goodwin AJ, et al. Application of deacetylated poly-N-acetyl glucosamine nanoparticles for the delivery of miR-126 for the treatment of cecal ligation and puncture-induced sepsis. Inflammation. 2019;42(1):170–184. doi:10.1007/s10753-018-0882-8
   PubMed Web of Science ®Google Scholar
• Handa M, Sharma A, Verma RK, Shukla R. Polycaprolactone based nano-carrier for co-administration of moxifloxacin and rutin and its in-vitro evaluation for sepsis. J Drug Deliv Sci Technol. 2019;54:101286. doi:10.1016/j.jddst.2019.101286
   Web of Science ®Google Scholar
• Hassan A, Ikram A, Raza A, et al. Therapeutic potential of novel mastoparan-chitosan nanoconstructs against clinical MDR acinetobacter baumannii: in silico, in vitro and in vivo studies. Int J Nanomedicine. 2021;16:3755–3773. doi:10.2147/IJN.S296717
   PubMed Web of Science ®Google Scholar
• Galanzha EI, Shashkov E, Sarimollaoglu M, et al. In vivo magnetic enrichment, photoacoustic diagnosis, and photothermal purging of infected blood using multifunctional gold and magnetic nanoparticles. PLoS One. 2012;7(9):e45557. doi:10.1371/journal.pone.0045557
   PubMed Web of Science ®Google Scholar
• Kim JW, Galanzha EI, Zaharoff DA, Griffin RJ, Zharov VP. Nanotheranostics of circulating tumor cells, infections and other pathological features in vivo. Mol Pharm. 2013;10(3):813–830. doi:10.1021/mp300577s
   PubMedGoogle Scholar
• Lykov AP. The therapeutic efficiency of mechanochemically synthesized compositions of nanostructured particles of silicium dioxide and antibiotics at experimental sepsis in (CBA×C57Bl6) F1 mice. Siberian Scientific Med J. 2012;32(3):21–26.
   Google Scholar
• Shukla P, Verma AK, Dewangan J, et al. Chitosan coated curcumin nanocrystals augment pharmacotherapy via improved pharmacokinetics and interplay of NFκB, Keap1 and Nrf2 expression in Gram negative sepsis. RSC Adv. 2015;5(70):57006–57020. doi:10.1039/C5RA06786C
   Web of Science ®Google Scholar
• Liang Z, Yang Y, Yu G, et al. Engineering aluminum hydroxyphosphate nanoparticles with well-controlled surface property to enhance humoral immune responses as vaccine adjuvants. Biomaterials. 2021;275:120960. doi:10.1016/j.biomaterials.2021.120960
   PubMed Web of Science ®Google Scholar
• Papafilippou L, Claxton A, Dark P, Kostarelos K, Hadjidemetriou M. Nanotools for sepsis diagnosis and treatment. Adv Healthc Mater. 2021;10(1):e2001378. doi:10.1002/adhm.202001378
   PubMed Web of Science ®Google Scholar
• Farokhzad OC, Langer R. Impact of nanotechnology on drug delivery. ACS Nano. 2009;3(1):16–20. doi:10.1021/nn900002m
   PubMed Web of Science ®Google Scholar
• Bayda S, Adeel M, Tuccinardi T, Cordani M, Rizzolio F. The history of nanoscience and nanotechnology: from chemical-physical applications to nanomedicine. Molecules. 2019;25(1):112. doi:10.3390/molecules25010112
   PubMed Web of Science ®Google Scholar
• Ellis D. Amphotericin B: spectrum and resistance. J Antimicrob Chemother. 2002;49(Suppl 1):7–10. doi:10.1093/jac/49.suppl_1.7
   PubMed Web of Science ®Google Scholar
• Alves D, Vaz AT, Grainha T, Rodrigues CF, Pereira MO. Design of an antifungal surface embedding liposomal amphotericin B through a mussel adhesive-inspired coating strategy. Front Chem. 2019;7:431. doi:10.3389/fchem.2019.00431
   PubMed Web of Science ®Google Scholar
• Groll AH, Rijnders BJA, Walsh TJ, Adler-Moore J, Lewis RE, Brüggemann RJM. Clinical pharmacokinetics, pharmacodynamics, safety and efficacy of liposomal amphotericin B. Clin Infect Dis. 2019;68(Suppl 4):S260–S274. doi:10.1093/cid/ciz076
   PubMedGoogle Scholar
• Walsh TJ, Goodman JL, Pappas P, et al. Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study. Antimicrob Agents Chemother. 2001;45(12):3487–3496. doi:10.1128/AAC.45.12.3487-3496.2001
   PubMed Web of Science ®Google Scholar
• Mocan L, Matea C, Tabaran FA, et al. Selective in vitro photothermal nano-therapy of MRSA infections mediated by IgG conjugated gold nanoparticles. Sci Rep. 2016;6:39466. doi:10.1038/srep39466
   PubMed Web of Science ®Google Scholar
• Stone NR, Bicanic T, Salim R, Hope W. Liposomal amphotericin B (AmBisome(®)): a review of the pharmacokinetics, pharmacodynamics, clinical experience and future directions. Drugs. 2016;76(4):485–500. doi:10.1007/s40265-016-0538-7
   PubMed Web of Science ®Google Scholar
• Min Y, Caster JM, Eblan MJ, Wang AZ. Clinical translation of nanomedicine. Chem Rev. 2015;115(19):11147–11190. doi:10.1021/acs.chemrev.5b00116
   PubMed Web of Science ®Google Scholar
• Zhu X, Radovic-Moreno AF, Wu J, Langer R, Shi J. Nanomedicine in the management of microbial infection-overview and perspectives. Nano Today. 2014;9(4):478–498. doi:10.1016/j.nantod.2014.06.003
   PubMed Web of Science ®Google Scholar
• Etheridge ML, Campbell SA, Erdman AG, Haynes CL, Wolf SM, McCullough J. The big picture on nanomedicine: the state of investigational and approved nanomedicine products. Nanomedicine. 2013;9(1):1–14. doi:10.1016/j.nano.2012.05.013
   PubMed Web of Science ®Google Scholar
• Farjadian F, Ghasemi A, Gohari O, Roointan A, Karimi M, Hamblin MR. Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities. Nanomedicine. 2019;14(1):93–126. doi:10.2217/nnm-2018-0120
   PubMed Web of Science ®Google Scholar
• Guggenbichler JP. Central venous catheter associated infections pathophysiology, incidence, clinical diagnosis, and prevention-a review. Materwiss Werksttech. 2003;34:1145–1154. doi:10.1002/mawe.200300712
   Web of Science ®Google Scholar
• Rauschmann MA, Wichelhaus TA, Stirnal V, et al. Nanocrystalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections. Biomaterials. 2005;26(15):2677–2684. doi:10.1016/j.biomaterials.2004.06.045
   PubMed Web of Science ®Google Scholar
• Wijnhoven SWP, Peijnenburg W, Herberts CA, et al. Nano-silver-a review of available data and knowledge gaps in human and environmental risk assessment. Nanotoxicology. 2009;3(2):109–138. doi:10.1080/17435390902725914
   Web of Science ®Google Scholar
• Kampf G, Dietze B, Grosse-Siestrup C, Wendt C, Martiny H. Microbicidal activity of a new silver-containing polymer, SPI-ARGENT II. Antimicrob Agents Chemother. 1998;42(9):2440–2442. doi:10.1128/AAC.42.9.2440
   PubMed Web of Science ®Google Scholar
• Massè A, Bruno A, Bosetti M, Biasibetti A, Cannas M, Gallinaro P. Prevention of pin track infection in external fixation with silver coated pins: clinical and microbiological results. J Biomed Mater Res. 2000;53(5):600–604. doi:10.1002/1097-4636(200009)53:5<600::AID-JBM21>3.0.CO;2-D
   PubMed Web of Science ®Google Scholar
• Rice TW, Wheeler AP, Bernard GR, et al. A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis. Crit Care Med. 2010;38(8):1685–1694. doi:10.1097/CCM.0b013e3181e7c5c9
   PubMed Web of Science ®Google Scholar
• Bhattacharyya S, Wang W, Tamaki Z, et al. Pharmacological inhibition of toll-like receptor-4 signaling by TAK242 prevents and induces regression of experimental organ fibrosis. Front Immunol. 2018;9:2434. doi:10.3389/fimmu.2018.02434
   PubMed Web of Science ®Google Scholar
• Sha T, Sunamoto M, Kitazaki T, Sato J, Ii M, Iizawa Y. Therapeutic effects of TAK-242, a novel selective Toll-like receptor 4 signal transduction inhibitor, in mouse endotoxin shock model. Eur J Pharmacol. 2007;571(2–3):231–239. doi:10.1016/j.ejphar.2007.06.027
   PubMed Web of Science ®Google Scholar
• Segal E. Testing antifungal vaccines in an animal model of invasive candidiasis and in human mucosal candidiasis. Methods Mol Biol. 2017;1625:343–353.
   PubMedGoogle Scholar
• Gov. Safety and immunogenicity study of a virosomal vaccine against recurrent vulvovaginal candida infection (clinical trial). Available from:https://clinicaltrials.gov/ct2/show/NCT01067131. NLM identifier: NCT01067131. Accessed February 11, 2010.
   Google Scholar
• Hinz B, Jauch O, Noky T, Friesecke S, Abel P, Kaiser R. CytoSorb, a novel therapeutic approach for patients with septic shock: a case report. Int J Artif Organs. 2015;38(8):461–464. doi:10.5301/ijao.5000429
   PubMed Web of Science ®Google Scholar
• Brouwer WP, Duran S, Kuijper M, Ince C. Hemoadsorption with CytoSorb shows a decreased observed versus expected 28-day all-cause mortality in ICU patients with septic shock: a propensity-score-weighted retrospective study. Crit Care. 2019;23(1):317. doi:10.1186/s13054-019-2588-1
   PubMed Web of Science ®Google Scholar
• Mehta Y, Mehta C, Kumar A, et al. Experience with hemoadsorption (CytoSorb®) in the management of septic shock patients. World J Crit Care Med. 2020;9(1):1–12. doi:10.5492/wjccm.v9.i1.1
   PubMedGoogle Scholar
• Schädler D, Pausch C, Heise D, et al. The effect of a novel extracorporeal cytokine hemoadsorption device on IL-6 elimination in septic patients: a randomized controlled trial. PLoS One. 2017;12(10):e0187015. doi:10.1371/journal.pone.0187015
   PubMed Web of Science ®Google Scholar
• Friesecke S, Stecher SS, Gross S, Felix SB, Nierhaus A. Extracorporeal cytokine elimination as rescue therapy in refractory septic shock: a prospective single-center study. J Artif Organs. 2017;20(3):252–259. doi:10.1007/s10047-017-0967-4
   PubMed Web of Science ®Google Scholar
• Caster JM, Patel AN, Zhang T, Wang A. Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017;9(1):e1416. doi:10.1002/wnan.1416
   Web of Science ®Google Scholar
• Wang L, Chen S, Pei W, Huang B, Niu C. Magnetically targeted erythrocyte membrane coated nanosystem for synergistic photothermal/chemotherapy of cancer. J Mater Chem B. 2020;8(18):4132–4142. doi:10.1039/D0TB00364F
   PubMed Web of Science ®Google Scholar
• Xia Q, Zhang Y, Li Z, Hou X, Feng N. Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application. Acta Pharm Sin B. 2019;9(4):675–689. doi:10.1016/j.apsb.2019.01.011
   PubMed Web of Science ®Google Scholar
• Tang Y, Wang X, Li J, et al. Overcoming the reticuloendothelial system barrier to drug delivery with a ”Don’t-Eat-Us” strategy. ACS Nano. 2019;13(11):13015–13026. doi:10.1021/acsnano.9b05679
   PubMed Web of Science ®Google Scholar
• Lu X, Xu P, Ding HM, Yu YS, Huo D, Ma YQ. Tailoring the component of protein Corona via simple chemistry. Nat Commun. 2019;10(1):4520. doi:10.1038/s41467-019-12470-5
   PubMedGoogle Scholar
• Elechalawar CK, Hossen MN, McNally L, Bhattacharya R, Mukherjee P. Analysing the nanoparticle-protein Corona for potential molecular target identification. J Control Release. 2020;322:122–136. doi:10.1016/j.jconrel.2020.03.008
   PubMed Web of Science ®Google Scholar
• Yan J, Bassler BL. Surviving as a community: antibiotic tolerance and persistence in bacterial biofilms. Cell Host Microbe. 2019;26(1):15–21. doi:10.1016/j.chom.2019.06.002
   PubMed Web of Science ®Google Scholar
• Grande R, Puca V, Muraro R. Antibiotic resistance and bacterial biofilm. Expert Opin Ther Pat. 2020;30(12):897–900. doi:10.1080/13543776.2020.1830060
   PubMed Web of Science ®Google Scholar
• Yang S, Tang Q, Chen L, et al. Cationic lipid-based intracellular delivery of bacterial effectors for rewiring malignant cell signaling. Angew Chem Int Ed Engl. 2020;59(41):18087–18094. doi:10.1002/anie.202009572
   PubMed Web of Science ®Google Scholar
• Uhle F, Lichtenstern C, Brenner T, Weigand MA. Pathophysiology of sepsis. Anasthesiol Intensivmed Notfallmed Schmerzther. 2015;50(2):114–122. doi:10.1055/s-0041-100391
   PubMed Web of Science ®Google Scholar
• Salomão R, Ferreira BL, Salomão MC, Santos SS, Azevedo LCP, Brunialti MKC. Sepsis: evolving concepts and challenges. Braz J Med Biol Res. 2019;52(4):e8595. doi:10.1590/1414-431x20198595
   PubMed Web of Science ®Google Scholar